Am Fam Physician. 2023;108(5):513-514
Author disclosure: No relevant financial relationships.
| Drug | Dosage | Dose form | Cost* |
|---|---|---|---|
| Baricitinib | Initial dosage: 2 mg once daily | Tablets: 1 mg, | $2,770 (1-mg and 2-mg tablets) |
| (Olumiant) | If hair growth does not occur, increase to 4 mg once daily | 2 mg, 4 mg | $5,530 (4-mg tablets) |
Baricitinib (Olumiant) is labeled for the treatment of severe alopecia areata in adults.1 It is a Janus kinase inhibitor that interrupts cytokine signaling in the Janus kinase 1 and 2 pathways, leading to hair regrowth.2 Baricitinib is also labeled for the treatment of patients with certain types of rheumatoid arthritis and some patients hospitalized with COVID-19.1
Already a member/subscriber?
Log In
Subscribe
From $165- Immediate, unlimited access to all AFP content
- More than 130 CME credits/year
- AAFP app access
- Print delivery available
Issue Access
$59.95- Immediate, unlimited access to this issue's content
- CME credits
- AAFP app access
- Print delivery available
Purchase Access:
Learn More
